To test the role of Trem2 in plaque formation, Trem2ΔMФ or controls were continuously fed a tamoxifen-enriched HFD (TAM-HFD) for 8 weeks or 16 weeks to induce Trem2 deletion and drive atherosclerosis (Fig. 4a). The gene discussed is TREM2; the disease is atherosclerosis.